Soltamox
NDC Package 13632-123-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Soltamox is tamoxifen is used to treat breast cancer. Marketed by Rosemont Pharmaceuticals Ltd, this product is identified by NDC 13632-123 and is authorized under FDA application NDA021807.

Identification & Billing

NDC Package Code
13632-123-01
Package Description
1 BOTTLE in 1 CARTON / 150 mL in 1 BOTTLE
Product Code
13632-123
11-Digit Billing Format
13632012301
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Soltamox
Dosage Form
-
Usage Information
Tamoxifen is used to treat breast cancer. It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue.

Regulatory & Marketing

Labeler Name
Rosemont Pharmaceuticals Ltd
FDA Application #
NDA021807
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2012
End Marketing Date
08-01-2018
Listing Expiration
08-01-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13632-123-01 identifies a specific commercial package of 1 bottle in 1 carton / 150 ml in 1 bottle of Soltamox, labeled by Rosemont Pharmaceuticals Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rosemont Pharmaceuticals Ltd on October 01, 2012. The current certification is valid through August 01, 2018.

What are the primary indications for this medication?

Tamoxifen is used to treat breast cancer. It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue.

How is this Rosemont Pharmaceuticals Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13632012301. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
13632-123-01
11-Digit CMS (5-4-2)
13632-0123-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.